BIOLOGICS WORLD NORDIC 2020 - ONLINE EVENT
30-09-2020 - 08:41 - 03-09-2020 - 16:00
IMAPAC PTE LTD
Biologics World Nordic is a focused biologic drugs and vaccines conference in the Nordic region. It will bring together the network of the Nordic biologics industry including region’s smaller Biopharma, Big Pharma, International Biopharma, CMOs, CROs, Technocrats & Solution Providers. Partnership opportunities, scientific innovation, manufacturing best practices are at the centre stage waiting to be explored by potential global partners.
The global biologic medicines market is projected to exceed USD390 billion by 2020, by which time biologics will account for up to 28% by value of the worldwide market for pharmaceuticals. New biological medicines and other advanced technological production strengthen both Denmark’s and Sweden’s roles as countries to which life science is central.
Increased pressure on prices and the phasing in of a new generation of technology with biological medicines has led to large companies being forced to make cutbacks as well as new investments. For the past few years, a lot of investment in the biologics industry in the Nordic industry is taking place. For example, AstraZeneca, in 2015, has spent $285m on a new biologics manufacturing facility in Södertälje, Sweden, that it plans to have fully up and running by 2019. The plant will focus on the filling and packaging of protein therapeutics and, from 2018, supplying medicines for the clinical trial programs of AZ and its MedImmune subsidiary.
For instance, Norway and Denmark, where physicians have been at the heart of the decision making the process concerning biosimilar medicines, uptake of biosimilar infliximab has been rapid and sustained. These markets demonstrate that trusting and empowering physicians to make the right decisions is a critical component of ensuring the longer-term sustainability of the market.
Fees, registration etc. at https://www.imapac.com/en/business_conferences/biologics-world-nordic/